SPIRIVA påvirker den kliniske utviklingen av KOLS
|
GOLD 2007 anbefaler langtidsvirkende bronkodilatatorer som grunnleggende vedlikeholdsbehandling (2)
Referanser
1. Dagens Medisin. Nr. 3; 2007
2. Buist S, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease 2006.
3. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003;124:1743-1748.
4. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002;19:217-224.
5. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127:809-817.
6. Donohue JF et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. CHEST 2002;122:47-55.
7. Vincken W, van Noord JA, Greefhorst APM, et al, on behalf of the Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Eur Respir J. 2002;19:209-216.
8. Barnes PJ. The role of anticholinergics in Chronic Obstructive Pulmonary Disease. The American Journal of Medicine. 2004; 117: 24s-32s.
9. Dusser D, Bravo M-L and Iacono P, on behalf of the MISTRAL study group. The effects of tiotropium on exacerbations and airflow in patients with COPD. Eur Respir J.2006;27:547-555.
10. Niewoehner DE, Rice K, Cote C, et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator a randomized trial. Ann Intern Med. 2005;143:317-326
11. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther. 2005;18:75-81.
12. Maltais F, Hamilton A, Marciniuk D, et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005;128:1168-1178.
13. SPIRIVA® SPC (02.05.2006).